Streetbeat News

Earnings

GRRR

Gorilla Technology Group Inc. (NASDAQ:GRRR) has announced its financial guidance for 2024 and 2025, projecting significant revenue growth and profitability. The company expects 2024 revenues to reach $72 million with an EBITDA margin over 20% and net income over $10 million. For 2025, revenues are projected to surpass $90 million with net income exceeding $15 million. This growth is driven by new contracts and strategic partnerships in Asia, MENA, and Latin America.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:13 pm

CDIO

GLYC

LIXT

SHPH

TMDX

Several healthcare stocks experienced significant price movements in Tuesday's pre-market session. Notable gainers include GlycoMimetics, Shuttle Pharmaceuticals, and Lixte Biotechnology, while TransMedics Group and Cardio Diagnostics Holdings were among the biggest losers.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 12:08 pm

AREB

EFSH

JBI

NOTE

PITA

PXDT

TREX

Several industrial stocks experienced significant movements in Tuesday's pre-market session. Notable gainers include American Rebel Holdings, Heramba Electric, and Trex Co, while 1847 Holdings and Pixie Dust Technologies were among the losers.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 12:08 pm

CROX

CWH

DHI

VFC

Several consumer discretionary stocks experienced significant movements in Tuesday's pre-market session. VF Corp (VFC) and Camping World Holdings (CWH) saw notable gains following their earnings reports, while Crocs (CROX) and D.R. Horton (DHI) experienced declines after releasing their earnings.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 12:08 pm

AMKR

ATGL

BKYI

CETX

DTSS

HLIT

IVDA

PHUN

QUBT

SMX

VEEA

XRX

In Tuesday's pre-market session, several information technology stocks experienced significant movements. Notable gainers include BIO-key Intl, Cemtrex, Veea, Quantum Computing, Datasea, and Alpha Technology Group. On the losing side, Harmonic, Xerox Holdings, Iveda Solutions, Amkor Tech, Phunware, and SMX saw declines, with some companies reporting Q3 earnings.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 12:08 pm

CROX

CWH

DHI

VFC

Several consumer discretionary stocks experienced significant movements in Tuesday's pre-market session. VF Corp and Camping World Holdings saw notable gains following their earnings reports, while Crocs and D.R. Horton faced declines after releasing their earnings.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 12:08 pm

AMWL

BIOR

CDIO

GLYC

HCTI

IMRN

LIXT

NBY

PTIX

SHPH

TMDX

TRIB

In Tuesday's pre-market session, several healthcare stocks experienced significant price movements. GlycoMimetics, Shuttle Pharmaceuticals, Lixte Biotechnology, NovaBay Pharmaceuticals, Immuron, and Protagenic Therapeutics saw notable gains. Conversely, TransMedics Group, Cardio Diagnostics Holdings, Biora Therapeutics, Trinity Biotech, American Well, and Healthcare Triangle experienced declines.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 12:08 pm

AREB

EFSH

JBI

NOTE

PITA

TREX

The article highlights the pre-market movements of 12 industrial stocks, with American Rebel Holdings, Heramba Electric, and Trex Co among the gainers, while 1847 Holdings and Janus Intl Gr are notable losers. Trex Co and Janus Intl Gr released their Q3 earnings recently.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 12:08 pm

AMKR

ATGL

BKYI

CETX

DTSS

HLIT

IVDA

PHUN

QUBT

SMX

VEEA

XRX

In Tuesday's pre-market session, several information technology stocks experienced significant price movements. Notable gainers include BIO-key Intl, Cemtrex, Veea, Quantum Computing, Datasea, and Alpha Technology Group. On the losing side, Harmonic, Xerox Holdings, Iveda Solutions, Amkor Tech, Phunware, and SMX saw declines, with some affected by recent Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 12:07 pm

THC

Tenet Healthcare has revised its FY24 net operating revenues outlook to a range of $20.60B - $20.80B, slightly below the previous estimate. However, it has raised its adjusted EPS guidance to $11.12 - $11.73, surpassing the previous estimate.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:07 pm